Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/12149
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShah, Gaurang-
dc.date.accessioned2024-06-04T05:13:28Z-
dc.date.available2024-06-04T05:13:28Z-
dc.date.issued2024-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/12149-
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00842;-
dc.subjectDissertation Reporten_US
dc.subjectRegulatory Affairsen_US
dc.subject22MPHen_US
dc.subject22MPH804en_US
dc.subjectPDR00842-
dc.titlePost-Approval CMC Changel in Brazil and Europeen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00842_22MPH804.pdfPDR0084296.51 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.